<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:04:21Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9277499" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9277499</identifier>
        <datestamp>2022-07-28</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id>
              <journal-title-group>
                <journal-title>JAMA Network Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2574-3805</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9277499</article-id>
              <article-id pub-id-type="pmcid">PMC9277499</article-id>
              <article-id pub-id-type="pmc-uid">9277499</article-id>
              <article-id pub-id-type="pmid">35819787</article-id>
              <article-id pub-id-type="doi">10.1001/jamanetworkopen.2022.20696</article-id>
              <article-id pub-id-type="publisher-id">zoi220594</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Investigation</subject>
                </subj-group>
                <subj-group subj-group-type="online-only">
                  <subject>Online Only</subject>
                </subj-group>
                <subj-group subj-group-type="subject-area">
                  <subject>Pediatrics</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effect of the Family-Centered Advance Care Planning for Teens with Cancer Intervention on Sustainability of Congruence About End-of-Life Treatment Preferences</article-title>
                <subtitle>A Randomized Clinical Trial</subtitle>
                <alt-title alt-title-type="headline">Effect of FACE-TC on Sustainability of Congruence About End-of-Life Treatment</alt-title>
                <alt-title alt-title-type="running-head">Effect of FACE-TC on Sustainability of Congruence About End-of-Life Treatment</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Needle</surname>
                    <given-names>Jennifer Susan</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>MPH</degrees>
                  <xref rid="zoi220594aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Friebert</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi220594aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="zoi220594aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thompkins</surname>
                    <given-names>Jessica D.</given-names>
                  </name>
                  <degrees>BSN</degrees>
                  <degrees>RN</degrees>
                  <degrees>CPN</degrees>
                  <xref rid="zoi220594aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Grossoehme</surname>
                    <given-names>Daniel H.</given-names>
                  </name>
                  <degrees>DMin</degrees>
                  <degrees>MS</degrees>
                  <xref rid="zoi220594aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="zoi220594aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Baker</surname>
                    <given-names>Justin N.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi220594aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jiang</surname>
                    <given-names>JiJi</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref rid="zoi220594aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Jichuan</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220594aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="zoi220594aff8" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Lyon</surname>
                    <given-names>Maureen E.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi220594aff8" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                  <xref rid="zoi220594aff9" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="zoi220594aff10" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="zoi220594aff1"><label>1</label>Department of Pediatrics and Center for Bioethics, University of Minnesota, Minneapolis</aff>
              <aff id="zoi220594aff2"><label>2</label>Haslinger Family Pediatric Palliative Care Center, Akron Children’s Hospital, Akron, Ohio</aff>
              <aff id="zoi220594aff3"><label>3</label>Rebecca D. Considine Research Institute, Akron Children’s Hospital, Akron, Ohio</aff>
              <aff id="zoi220594aff4"><label>4</label>Division of Allergy and Immunology, Children’s National Hospital, Washington, DC</aff>
              <aff id="zoi220594aff5"><label>5</label>Division of Quality of Life and Palliative Care, St Jude Children’s Research Hospital, Memphis, Tennessee</aff>
              <aff id="zoi220594aff6"><label>6</label>Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland</aff>
              <aff id="zoi220594aff7"><label>7</label>Division of Biostatistics and Study Methodology, Center for Translational Research/Children’s National Research Institute, Children’s National Hospital, Washington, DC</aff>
              <aff id="zoi220594aff8"><label>8</label>Center for Translational Research/Children’s National Research Institute, Children’s National Hospital, Washington, DC</aff>
              <aff id="zoi220594aff9"><label>9</label>Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC</aff>
              <aff id="zoi220594aff10"><label>10</label>Division of Adolescent and Young Adult Medicine, Children’s National Hospital, Washington, DC</aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> May 19, 2022.</p>
                <p content-type="published-online"><bold>Published:</bold> July 12, 2022. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamanetworkopen.2022.20696</uri></p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. © 2022 Needle JS et al. <italic>JAMA Network Open</italic>.</p>
                <corresp id="zoi220594cor1"><bold>Corresponding Author:</bold> Maureen E. Lyon, PhD, Center for Translational Research/Children’s National Research Institute, Children’s National Hospital, 111 Michigan Ave NW, Washington, DC 20010-2970 (<email xlink:href="mlyon@childrensnational.org">mlyon@childrensnational.org</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions</bold>: Dr Wang and Ms Jiang had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p>
                <p><italic>Concept and design:</italic> Needle, Friebert, Baker, Wang, Lyon.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> All authors.</p>
                <p><italic>Drafting of the manuscript:</italic> Needle, Friebert, Grossoehme, Wang, Lyon.</p>
                <p><italic>Critical revision of the manuscript for important intellectual content:</italic> All authors.</p>
                <p><italic>Statistical analysis:</italic> Jiang, Wang.</p>
                <p><italic>Obtained funding:</italic> Lyon.</p>
                <p><italic>Administrative, technical, or material support:</italic> Needle, Friebert, Thompkins, Grossoehme, Lyon.</p>
                <p><italic>Supervision:</italic> Friebert, Thompkins, Grossoehme, Lyon.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Lyon reported receiving grants from NINR during the conduct of the study and holding the copyright to the Lyon Family Centered Advance Care Planning Survey. No other disclosures were reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This study was supported by award 5R01 NR015458 from the NIH NINR (Dr Lyon). This research was facilitated by the services and resources provided by grants UL1TR0000075 and UL1RR03198 from the Clinical and Translational Science Institute at Children’s National.</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                <p><bold>Disclaimer:</bold> The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.</p>
                <p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p>
                <p><bold>Additional Contributions:</bold> We are grateful to the adolescents and their families who participated in this study. We also thank the following staff members at Akron Children's Hospital, Children's National Hospital, St Jude Children's Research Hospital, and University of Minnesota Masonic Children's Hospital for their assistance with the intervention and/or data collection: Jessica Livingston, MPH; Susan M. Flesch, CRA; Robin Wilcox, BSN, RN; Jami S. Gattuso, MSN, RN, CPON; Jennifer Zabrowski, AA; Melanie Gattas, CRA, AA; Valerie Shaner, RRT, NPS; Aliana Martinez, PhD; Rachel Jenkins, MA; Elaine Churney, RN; and Kristine Allmendinger-Goertz, CCRC. These individuals received no additional compensation, outside of their usual salary, for their contributions.</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2022-07-12T10:00">
                <day>12</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>12</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>5</volume>
              <issue>7</issue>
              <elocation-id>e2220696</elocation-id>
              <history>
                <date date-type="received">
                  <day>16</day>
                  <month>1</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>19</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2022 Needle JS et al. <italic>JAMA Network Open</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2220696.pdf">jamanetwopen-e2220696.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.20696"/>
              <abstract abstract-type="teaser" specific-use="electronic">
                <p>This randomized clinical trial examines an intervention that supports and enables the discussion of advance directives between adolescents with cancer and their families.</p>
              </abstract>
              <abstract abstract-type="key-points">
                <title>Key Points</title>
                <sec id="ab-zoi220594-1">
                  <title>Question</title>
                  <p>Does the Family-Centered Advance Care Planning for Teens with Cancer (FACE-TC) intervention sustain agreement about end-of-life treatment preferences 18 months after the intervention?</p>
                </sec>
                <sec id="ab-zoi220594-2">
                  <title>Findings</title>
                  <p>In this randomized clinical trial involving 126 adolescent-family dyads, those who received FACE-TC had a 3-fold greater odds of being in the high-congruence class over 12 months, but this significant difference was not sustained at 18 months. Adolescents in the FACE-TC group were significantly more likely to have an advance directive in the electronic health record at study closeout than those in the treatment as usual group (80% vs 19%).</p>
                </sec>
                <sec id="ab-zoi220594-3">
                  <title>Meaning</title>
                  <p>Findings of this trial suggest that FACE-TC participation improved congruence between adolescents and their families regarding end-of-life treatment preferences for 1 year; yearly follow-up sessions are indicated.</p>
                </sec>
              </abstract>
              <abstract>
                <sec id="ab-zoi220594-4">
                  <title>Importance</title>
                  <p>The effect of pediatric advance care planning (pACP) on the sustainability of end-of-life treatment preference congruence between adolescents with cancer and their families has not been examined.</p>
                </sec>
                <sec id="ab-zoi220594-5">
                  <title>Objective</title>
                  <p>To evaluate the longitudinal efficacy of the Family-Centered Advance Care Planning for Teens with Cancer (FACE-TC) intervention to sustain adolescent-family congruence about end-of-life treatment preferences.</p>
                </sec>
                <sec id="ab-zoi220594-6">
                  <title>Design, Setting, and Participants</title>
                  <p>This multisite, assessor-blinded, randomized clinical trial enrolled adolescents with cancer (aged 14-21 years) and their family members from 4 pediatric hospitals between July 16, 2016, and April 30, 2019. Participants were randomized 2:1 to FACE-TC (intervention group) or treatment as usual (control group) and underwent 5 follow-up visits over an 18-month postintervention period. Intention-to-treat analyses were conducted from March 9, 2021, to April 14, 2022.</p>
                </sec>
                <sec id="ab-zoi220594-7">
                  <title>Exposures</title>
                  <p>Adolescent-family dyads randomized to the FACE-TC group received 3 weekly 60-minute sessions consisting of the discussion and/or completion of the Lyon Family-Centered Advance Care Planning Survey (session 1), Respecting Choices Next Steps pACP conversation (session 2), and Five Wishes advance directive (session 3). Dyads in the control group received treatment as usual. Both groups received pACP information.</p>
                </sec>
                <sec id="ab-zoi220594-8">
                  <title>Main Outcomes and Measures</title>
                  <p>Congruence was measured by completion of the Statement of Treatment Preferences (a document that discusses 4 hypothetical clinical situations and treatment choices for each scenario: continue all treatments, stop all efforts to keep me alive, or unsure) after session 2 (time 1) and at 3 months (time 2), 6 months (time 3), 12 months (time 4), and 18 months (time 5) after intervention. The influence of FACE-TC on the trajectory of congruence over time was measured by longitudinal latent class analysis.</p>
                </sec>
                <sec id="ab-zoi220594-9">
                  <title>Results</title>
                  <p>A total of 252 participants (126 adolescent-family dyads) were randomized. Adolescents (mean [SD] age, 17 [1.9] years) and family members (mean [SD] age, 46 [8.3] years) were predominantly female (72 [57%] and 104 [83%]) and White individuals (100 [79%] and 103 [82%]). There was an 83% (104 of 126) retention at the 18-month assessment. Two latent classes of congruence over time were identified: high-congruence latent class (69 of 116 [60%]) and low-congruence latent class (47 of 116 [41%]). The dyads in the FACE-TC group had a 3-fold odds of being in the high-congruence latent class (odds ratio [OR], 3.22; 95% CI, 1.09-9.57) compared with the control group. Statistically significant differences existed at 12 months (β [SE] = 1.17 [0.55]; <italic>P</italic> = .03]) but not at 18 months (OR, 2.08; 95% CI, 0.92-4.69). In the high-congruence latent class, good agreement (agreement on 2 or 3 of 4 situations) increased over 12 months. White adolescents and families had significantly greater odds of congruence than a small population of American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, or multiracial adolescents and families (OR, 3.97; 95% CI, 1.07-14.69).</p>
                </sec>
                <sec id="ab-zoi220594-10">
                  <title>Conclusions and Relevance</title>
                  <p>Results of this trial showed that, for those who received the FACE-TC intervention, the families’ knowledge of their adolescents’ end-of-life treatment preferences was sustained for 1 year, suggesting yearly follow-up sessions. Race and ethnicity–based differences in the sustainability of this knowledge reflect a difference in the effect of the intervention and require further study.</p>
                </sec>
                <sec id="ab-zoi220594-11">
                  <title>Trial Registration</title>
                  <p>ClinicalTrials.gov Identifier: <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT02693665?term=NCT02693665&amp;draw=2&amp;rank=1" ext-link-type="uri">NCT02693665</ext-link></p>
                </sec>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-ZOI220594">
              <title>Introduction</title>
              <p>Adolescents with a serious illness, their families, and clinicians concur that pediatric advance care planning (pACP) is appropriate.<sup><xref rid="zoi220594r1" ref-type="bibr">1</xref>,<xref rid="zoi220594r2" ref-type="bibr">2</xref>,<xref rid="zoi220594r3" ref-type="bibr">3</xref>,<xref rid="zoi220594r4" ref-type="bibr">4</xref></sup> Key elements of pACP in this population<sup><xref rid="zoi220594r1" ref-type="bibr">1</xref>,<xref rid="zoi220594r2" ref-type="bibr">2</xref>,<xref rid="zoi220594r3" ref-type="bibr">3</xref>,<xref rid="zoi220594r4" ref-type="bibr">4</xref>,<xref rid="zoi220594r5" ref-type="bibr">5</xref>,<xref rid="zoi220594r6" ref-type="bibr">6</xref></sup> include (1) giving adolescents a voice in their own end-of-life care, (2) initiating early pACP conversations to close gaps in understanding,<sup><xref rid="zoi220594r7" ref-type="bibr">7</xref></sup> (3) documenting advance directives in the electronic health record (EHR), and (4) sharing pACP conversations with the treating clinicians to support communication before a medical crisis.<sup><xref rid="zoi220594r8" ref-type="bibr">8</xref></sup> Various models of pACP for adolescents with a serious illness are being developed,<sup><xref rid="zoi220594r9" ref-type="bibr">9</xref>,<xref rid="zoi220594r10" ref-type="bibr">10</xref>,<xref rid="zoi220594r11" ref-type="bibr">11</xref>,<xref rid="zoi220594r12" ref-type="bibr">12</xref>,<xref rid="zoi220594r13" ref-type="bibr">13</xref></sup> along with tools to guide conversations.<sup><xref rid="zoi220594r14" ref-type="bibr">14</xref>,<xref rid="zoi220594r15" ref-type="bibr">15</xref>,<xref rid="zoi220594r16" ref-type="bibr">16</xref></sup></p>
              <p>Although ongoing conversations are recommended,<sup><xref rid="zoi220594r17" ref-type="bibr">17</xref>,<xref rid="zoi220594r18" ref-type="bibr">18</xref></sup> optimal timing has not been empirically demonstrated.<sup><xref rid="zoi220594r19" ref-type="bibr">19</xref>,<xref rid="zoi220594r20" ref-type="bibr">20</xref></sup> Timing is important for adolescents with cancer, the leading cause of disease-related death in this age group.<sup><xref rid="zoi220594r21" ref-type="bibr">21</xref>,<xref rid="zoi220594r22" ref-type="bibr">22</xref>,<xref rid="zoi220594r23" ref-type="bibr">23</xref></sup> Adolescents with cancer prefer to talk about pACP from the time of diagnosis and not while hospitalized or if they are dying.<sup><xref rid="zoi220594r7" ref-type="bibr">7</xref>,<xref rid="zoi220594r24" ref-type="bibr">24</xref></sup> Determining whether early pACP conversations are effective over time is critical to patient-centered or family-supported care. The unanswered question is whether families can sustain knowledge of the patients’ treatment preferences over time, even as these preferences change, as demonstrated among adolescents<sup><xref rid="zoi220594r25" ref-type="bibr">25</xref></sup> and adults<sup><xref rid="zoi220594r26" ref-type="bibr">26</xref></sup> with HIV.</p>
              <p>A theoretically guided, single-site, 3-session intervention called Family-Centered Advance Care Planning for Teens with Cancer (FACE-TC) was pilot-tested and informed by community-based participatory research.<sup><xref rid="zoi220594r27" ref-type="bibr">27</xref></sup> The pilot trial resulted in congruence about end-of-life treatment preferences.<sup><xref rid="zoi220594r28" ref-type="bibr">28</xref>,<xref rid="zoi220594r29" ref-type="bibr">29</xref></sup> The FACE (Family-Centered) model has also been pilot-tested in adolescents and young adults, aged 14 to 27 years, who underwent bone marrow transplant.<sup><xref rid="zoi220594r30" ref-type="bibr">30</xref></sup> In that study, the participants were capable of meaningful deliberation about future treatment choices,<sup><xref rid="zoi220594r30" ref-type="bibr">30</xref></sup> and their decision-making was influenced by consideration for family, quality of life, and awareness of self.<sup><xref rid="zoi220594r31" ref-type="bibr">31</xref></sup></p>
              <p>The primary aim of this randomized clinical trial was to evaluate the longitudinal efficacy of FACE-TC to sustain adolescent-family congruence about end-of-life treatment preferences. We hypothesized that (1) participants who received FACE-TC would be better at retaining congruence over time compared with participants in the control group who received treatment as usual, (2) the development of congruence would not be homogeneous and that FACE-TC would influence congruence trajectories over time, and (3) adolescents who received FACE-TC would be more likely to have advance directives documented in the EHR at the study closeout compared with control adolescents.</p>
            </sec>
            <sec id="H1-2-ZOI220594">
              <title>Methods</title>
              <p>The institutional review board at each study site approved the trial protocol (<xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 1</xref>), and an external safety monitoring committee monitored the trial. Participants provided written informed consent or assent. We followed the Consolidated Standards of Reporting Trials (<ext-link xlink:href="https://www.equator-network.org/reporting-guidelines/consort/" ext-link-type="uri">CONSORT</ext-link>) reporting guideline.</p>
              <sec id="H2-1-ZOI220594">
                <title>Study Design, Participants, and Setting</title>
                <p>Full details of the trial have been published.<sup><xref rid="zoi220594r32" ref-type="bibr">32</xref></sup> Briefly, this multisite, assessor-blinded, intention-to-treat randomized clinical trial enrolled adolescent-family dyads between July 16, 2016, and April 30, 2019. Dyads were recruited from 4 quaternary pediatric hospitals: Akron Children’s Hospital (Akron, Ohio), Children’s National Hospital (Washington, DC), St Jude Children’s Research Hospital (Memphis, Tennessee), and University of Minnesota Masonic Children’s Hospital (Minneapolis, Minnesota).</p>
                <p>Inclusion criteria for adolescents were diagnosis of cancer, 14 to 21 years of age at enrollment, no intellectual disabilities that would interfere with decision-making, ability to speak English (see protocol for Spanish speakers<sup><xref rid="zoi220594r13" ref-type="bibr">13</xref></sup>), and not in foster care. Eligibility criteria for a family member were as a legal guardian (if the adolescent was younger than 18 years) or as the chosen surrogate decision maker (if the adolescent was 18 years or older at enrollment), ability to cognitively engage, ability to speak English, and knowledge of the adolescent’s diagnosis. After enrolling, all participants underwent secondary screening for the exclusion criteria: severe depression,<sup><xref rid="zoi220594r33" ref-type="bibr">33</xref></sup> homicidality,<sup><xref rid="zoi220594r34" ref-type="bibr">34</xref></sup> suicidality,<sup><xref rid="zoi220594r33" ref-type="bibr">33</xref></sup> and/or psychosis.<sup><xref rid="zoi220594r34" ref-type="bibr">34</xref></sup></p>
                <p>Participants received compensation in the amount of $25 for visits 1 to 4 and $35 for visits 5 to 8. Race and ethnicity were identified by participants, per study funder requirements.</p>
              </sec>
              <sec id="H2-2-ZOI220594">
                <title>Procedures and Randomization</title>
                <p>We completed training in the trial protocol. We conducted yearly booster sessions for study staff. Interventionists (including J.D.T.) were nurses who received certification in the Respecting Choices Next Steps program, which required online education about advance care planning (ACP) with continuing education credits and 12 hours of face-to-face training.<sup><xref rid="zoi220594r35" ref-type="bibr">35</xref>,<xref rid="zoi220594r36" ref-type="bibr">36</xref></sup> One of us (M.E.L.) provided monthly group supervision to interventionists by conference call, which involved video review of the Respecting Choices session and competency criteria checklist.</p>
                <p>After consulting with adolescents’ primary oncologists, assessors approached potentially eligible participants face-to-face during outpatient appointments. Visit 1 included enrollment; secondary screening; and, if eligible, completion of baseline questionnaires.</p>
                <p>Dyads were randomized 2:1 to either the FACE-TC intervention or treatment as usual (<xref rid="zoi220594f1" ref-type="fig">Figure 1</xref>). Completion of baseline assessments in the REDCap (Research Electronic Data Capture; Vanderbilt University) database triggered randomization using a computer-generated randomization table. Interventionists notified the participants of their group assignment to protect assessor blinding. Blinded assessors read study questionnaires aloud to the participants. Questionnaires were administered separately to adolescents and their families.</p>
                <fig position="float" id="zoi220594f1" fig-type="figure">
                  <label>Figure 1. </label>
                  <caption>
                    <title>Study Flow Diagram of the Family-Centered Advance Care Planning for Teens with Cancer (FACE-TC) Trial Using Intention-to-Treat Design</title>
                    <p>ACP indicates advance care planning; FACE, Family-Centered.</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e2220696-g001" position="float"/>
                </fig>
              </sec>
              <sec id="H2-3-ZOI220594">
                <title>Exposures</title>
                <p>All dyads received usual care and a pACP booklet.<sup><xref rid="zoi220594r37" ref-type="bibr">37</xref></sup> Dyads who were randomized to the control group received treatment as usual. Dyads who were randomized to FACE-TC received three 60-minute sessions that were conducted weekly. In session 1, the Lyon Family-Centered Advance Care Planning Survey<sup><xref rid="zoi220594r7" ref-type="bibr">7</xref></sup> was administered separately to the adolescent and family member to prepare them for issues to be discussed in the next 2 sessions. In session 2, the Respecting Choices Next Steps pACP conversation guide<sup><xref rid="zoi220594r35" ref-type="bibr">35</xref>,<xref rid="zoi220594r36" ref-type="bibr">36</xref></sup> was discussed with the dyad, with the adolescent taking the lead, to explore the adolescent’s understanding of their cancer and its potential complications, experiences with death and dying, and end-of-life treatment preferences. In session 3, the Five Wishes,<sup><xref rid="zoi220594r38" ref-type="bibr">38</xref></sup> a legal advance directive in most US states, was completed by both the adolescent and family member. For adolescents younger than 18 years, their legal guardian’s signature was required on the Five Wishes document. A copy was given to the family member.</p>
                <p>The results and documents from these FACE-TC sessions were then communicated to clinicians in an email by the interventionist, who also entered the documents into the EHR. eTable 1 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref> describes the goals and processes of each session.</p>
              </sec>
              <sec id="H2-4-ZOI220594">
                <title>Primary Outcome Measure </title>
                <p>The Statement of Treatment Preferences is a structured and standardized way to document adolescents’ specific treatment preferences. Family members completed a Statement of Treatment Preferences form separately according to their understanding of the adolescent’s preferences. Four cancer-specific situations and the benefits and burdens of treatment options were discussed: (1) long hospitalization with low chance of survival; (2) treatment to extend life by no more than 3 months, with serious adverse effects; (3) physical impairment; and (4) profound cognitive impairment. Choices for each situation were as follows: to continue all treatments so I could live as long as possible (staying alive is most important to me no matter what), to stop all efforts to keep me alive (my definition of living well is more important than length of life), or unsure. The Statement of Treatment Preferences method has been used in multiple adolescent<sup><xref rid="zoi220594r25" ref-type="bibr">25</xref>,<xref rid="zoi220594r28" ref-type="bibr">28</xref>,<xref rid="zoi220594r30" ref-type="bibr">30</xref></sup> and adult studies,<sup><xref rid="zoi220594r26" ref-type="bibr">26</xref>,<xref rid="zoi220594r39" ref-type="bibr">39</xref></sup> increasing its replicability.</p>
                <p>Dyadic responses for data analysis were recoded into 2 categories for each situation: congruent vs noncongruent. Unsure responses were coded as noncongruent (ie, no agreement to take a course of action). As a data-reduction strategy, 3 levels of overall agreement were generated based on preferences on the 4 cancer-related situations (poor congruence, agreement in 0-1 situation; good congruence, agreement in 2-3 situations; perfect congruence, agreement in all 4 situations).</p>
              </sec>
              <sec id="H2-5-ZOI220594">
                <title>Secondary and Exploratory Outcomes Measures</title>
                <p>We developed a standardized EHR-based form for data abstraction of any goals of care or advance directives in the EHR before the study and at study closeout.<sup><xref rid="zoi220594r29" ref-type="bibr">29</xref></sup> Goals-of-care conversations were operationalized as a progress note, family meeting note, or palliative care note in the EHR concerning illness understanding or end-of-life treatment preferences. Data abstraction was conducted by a blinded assessor.</p>
              </sec>
              <sec id="H2-6-ZOI220594">
                <title>Demographic Characteristics</title>
                <p>A standardized form was used to collect self-reported age, sex, gender, and race and ethnicity as well as family-reported educational level and employment status. Reported household income and household size determined the 2016 federal poverty level of the participants. Data abstraction included cancer diagnosis, date of diagnosis, history of relapse, history of bone marrow transplant, and on or off active treatment status.</p>
              </sec>
              <sec id="H2-7-ZOI220594">
                <title>Statistical Analysis</title>
                <p>All intention-to-treat analyses were by original randomization. We used longitudinal latent class analysis (LLCA)<sup><xref rid="zoi220594r40" ref-type="bibr">40</xref>,<xref rid="zoi220594r41" ref-type="bibr">41</xref>,<xref rid="zoi220594r42" ref-type="bibr">42</xref>,<xref rid="zoi220594r43" ref-type="bibr">43</xref>,<xref rid="zoi220594r44" ref-type="bibr">44</xref>,<xref rid="zoi220594r45" ref-type="bibr">45</xref></sup> to explore potential latent classes of dyads with respect to trajectories of congruence over time. Longitudinal latent class analysis characterizes both within-person variation and between-person variation and identifies latent classes according to groupings of similar patterns of outcome growth trajectories across time with no assumption about the form of outcome change (ie, an agnostic, data-driven approach). The LLCA models with 3 time points were estimated as time 1 to time 3, time 1 to time 4, and time 1 to time 5. Description of the congruence measure by latent classes is provided in the eAppendix 2 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p>
                <p>Next, we built a logistic regression model using a 3-step method to estimate the effect of FACE-TC, while controlling for covariates. Details on the LLCA are provided in the eAppendix 1 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>. All models were estimated using Mplus, version 8.6 (Muthén and Muthén).<sup><xref rid="zoi220594r45" ref-type="bibr">45</xref></sup></p>
                <p>To evaluate the efficacy of FACE-TC for early completion of pACP goals of care and advance directives, we used χ<sup>2</sup> statistics to assess the difference in completion of pACP goals of care and advance directives between participants in the FACE-TC group and those in the control group. Next, exact logistic regression was applied to test the effect of FACE-TC on documentation of goals of care and advance directives in the EHR, while controlling for sociodemographic characteristics.</p>
                <p>Data were entered into REDCap, version 8.10.18-2020.<sup><xref rid="zoi220594r46" ref-type="bibr">46</xref></sup> Statistical significance was set at α = .05. Analyses were conducted from March 9, 2021, to April 14, 2022, using SAS, version 9.4 (SAS Institute Inc).</p>
              </sec>
            </sec>
            <sec id="H1-3-ZOI220594">
              <title>Results</title>
              <sec id="H2-8-ZOI220594">
                <title>Participant Characteristics</title>
                <p>A total of 252 participants (126 adolescent-family dyads) were randomized (<xref rid="zoi220594f1" ref-type="fig">Figure 1</xref>). Adolescents had a mean (SD) age of 17 (1.9) years; 72 participants were female (57%), 54 were male (43%), and 100 were White individuals (79%) (<xref rid="zoi220594t1" ref-type="table">Table 1</xref>). Family members had a mean (SD) age of 46 (8.3) years; were predominantly female (104 [83%]) and White (103 [82%]) individuals; and included 94 mothers (75%), 19 fathers (15%), and 10 adolescent-chosen nonbiological surrogate decision makers (8%). There were no study-related adverse events.</p>
                <table-wrap position="float" id="zoi220594t1">
                  <label>Table 1. </label>
                  <caption>
                    <title>Baseline Demographic Characteristics of Adolescents With Cancer and Their Families </title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="39.21%" span="1"/>
                    <col width="14.05%" span="1"/>
                    <col width="16.33%" span="1"/>
                    <col width="14.05%" span="1"/>
                    <col width="16.36%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Characteristic</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Adolescents, No. (%)</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Families, No. (%)</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">FACE-TC group</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Treatment as usual group</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">FACE-TC group</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Treatment as usual group</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of participants</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">83</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">43</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">83</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">43</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, mean (SD) [range], y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16.9 (1.8) [14-20]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">17.0 (2.0) [14-20]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">45.6 (8.2) [19-67]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">46.5 (8.4) [20-63]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">45 (54)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">27 (63)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67 (81)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">37 (86)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">38 (46)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16 (37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16 (19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (14)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race<xref rid="zoi220594t1n1" ref-type="table-fn"><sup>a</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> American Indian or Alaska Native</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (2)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Asian</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black or African American</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (14)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (9)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">63 (76)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">37 (86)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">68 (82)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">35 (81)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> More than 1 race</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (7)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Declined to answer</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Ethnicity<xref rid="zoi220594t1n1" ref-type="table-fn"><sup>a</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic or Latino</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Not Hispanic or Latino</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">76 (92)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">40 (93)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">79 (95)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">42 (98)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Declined to answer</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (2)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Educational level</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> No high school diploma or GED equivalency</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">45 (54)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">26 (60)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High school or GED equivalency</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">28 (34)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16 (19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7 (16)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Some college but no bachelor’s degree</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (21)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">31 (37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">17 (40)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Bachelor’s, master’s, doctoral, or professional degree</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">34 (41)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">19 (44)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Declined to answer</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Household income, FPL</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Equal to or below</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">21 (25)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (28)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 101%-200%</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">23 (28)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (33)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 201%-300%</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (17)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (12)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &gt;300%</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">23 (28)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 (23)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Declined to answer</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (5)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Relationship</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Biological</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">76 (92)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">37 (86)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Nonbiological</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (14)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">On active treatment?</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Yes</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">20 (24)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7 (16)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> No</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">63 (76)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">36 (84)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Cancer diagnosis</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Leukemia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">26 (31)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16 (37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Solid tumors</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">21 (25)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Brain tumor</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16 (19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Lymphoma</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (21)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="zoi220594t1n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Length of time since diagnosis, mean (SD) [range], mo</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">81 (68) [1-232]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">70 (60) [2-198]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: FACE-TC, Family-Centered Advance Care Planning for Teens with Cancer; FPL, federal poverty level; GED, General Educational Development; NA, not applicable.</p>
                    <fn id="zoi220594t1n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Race and ethnicity were self-reported by participants.</p>
                    </fn>
                    <fn id="zoi220594t1n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Other included totally resected World Health Organization grade II ependymoma, Ewing sarcoma in left scalp, germ cell tumor of right testis, nonosseous retroperitoneal Ewing sarcoma, papillary thyroid carcinoma, plexiform neurofibroma, Wilm tumor in left kidney, melanoma, and GATA2-related myelodysplastic syndrome, neuroblastoma, pilonidal abscess, synovial sarcoma of soft tissue, and metastatic melanoma.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The primary reason for declining participation was lack of time (76 of 203 dyads [37%]), whereas 46 dyads (23%) declined because at least 1 member of the dyad did not want to discuss ACP (<xref rid="zoi220594f1" ref-type="fig">Figure 1</xref>). Male adolescents were significantly more likely to decline participation (difference of 14%; 95% CI, 4%-25%; <italic>P</italic> = .02). There were no significant between-group differences in age, race and ethnicity, cancer diagnosis, and active treatment status between enrollees and decliners.</p>
                <p>Retention was 83% (104 of 126 dyads) at 18 months. Benchmarks were achieved: (1) enrollment of 130 dyads, (2) retention of more than 70% of dyads at the 18-month assessment, and (3) 90% of participants who began session 1 completed session 3 of the FACE-TC intervention.</p>
                <p>The LLCA models were estimated with different time points immediately after session 2 for dyads in the FACE-TC group or 3 weeks after baseline for the treatment as usual group (time 1) and at 3 months (time 2), 6 months (time 3), 12 months (time 4), and 18 months (time 5) after intervention. Two distinct latent classes were identified using 12 months of data: high-congruence latent class (69 of 116 [60%]) and low-congruence latent class (47 of 116 [41%]). Selected results of the 4 time data (time 1-time 4) of the LLCA for levels of agreement over time by latent class are shown in <xref rid="zoi220594f2" ref-type="fig">Figure 2</xref> and eTable 2 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>. The probabilities of poor agreement were lower in the high-congruence latent class and reached 0 at time 4 (<xref rid="zoi220594f2" ref-type="fig">Figure 2</xref>A) compared with the low-congruence latent class (<xref rid="zoi220594f2" ref-type="fig">Figure 2</xref>B). In the high-congruence latent class, FACE-TC affected the trajectory of congruence, with good agreement (agreement on 2 or 3 of 4 situations) increasing over 12 months and perfect agreement decreasing from time 1 to time 2 and then stabilizing (<xref rid="zoi220594f2" ref-type="fig">Figure 2</xref>A). Overall, dyadic agreement levels (poor, good, and perfect) varied across latent classes at each time point.</p>
                <fig position="float" id="zoi220594f2" fig-type="figure">
                  <label>Figure 2. </label>
                  <caption>
                    <title>Probability of Congruence Change Trajectories</title>
                    <p>Longitudinal latent class models were used to estimate the probability of congruence over time for each adolescent-family dyad and to classify dyads into groups with similar patterns. Lines indicate levels of agreement (poor, good, or perfect).</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e2220696-g002" position="float"/>
                </fig>
                <p><xref rid="zoi220594t2" ref-type="table">Table 2</xref> shows the actual effect of FACE-TC on class membership, with the mean probability of congruence. The dyads in the FACE-TC group had a 3-fold odds of being in the high-congruence latent class (odds ratio [OR], 3.22; 95% CI, 1.09-9.57), compared with the dyads in the treatment as usual group. Statistically significant differences existed at 12 months (β [SE] = 1.17 [0.55]; <italic>P</italic> = .03]) (eTable 3 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>) in the time 1 to time 4 model. White adolescents and families had significantly greater odds of membership in the high-congruence latent class than a small population of American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, or multiracial adolescents and families (OR, 3.97 [95% CI, 1.07-14.69]; β [SE] = 1.38 [0.67]; <italic>P</italic> = .04) (<xref rid="zoi220594t2" ref-type="table">Table 2</xref>; eTable 3 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>). The association of 18-month outcomes with latent class membership by intervention was not significant and had an OR of 2.08 (95% CI, 0.92-4.69).</p>
                <table-wrap position="float" id="zoi220594t2">
                  <?xpp 1.5col?>
                  <label>Table 2. </label>
                  <caption>
                    <title>Effect of FACE-TC on Latent Class Classification, Controlling for Covariates and Results of Logistic Regression Model for Time 1 to Time 4 (N = 117 Dyads)<xref rid="zoi220594t2n1" ref-type="table-fn"><sup>a</sup></xref></title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="61.57%" span="1"/>
                    <col width="38.43%" span="1"/>
                    <thead>
                      <tr>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Variable</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">OR (95% CI)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">FACE-TC</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.22 (1.09-9.57)<xref rid="zoi220594t2n2" ref-type="table-fn"><sup>b</sup></xref></td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Adolescent race and ethnicity</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.97 (1.07-14.69)<xref rid="zoi220594t2n2" ref-type="table-fn"><sup>b</sup></xref></td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="zoi220594t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Adolescent age, y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &lt;14</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 14-17</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.74 (0.61-4.96)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Adolescent sex</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.85 (0.64-5.37)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Family educational level</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &lt;High school</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High school diploma or GED equivalency</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.76 (0.23-2.53)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> ≥College or university degree </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.72 (0.38-7.71)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Family household income, FPL</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> After 2016</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> In or before 2016</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.67 (0.42-6.66)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: FACE-TC, Family-Centered Advance Care Planning for Teens with Cancer; FPL, federal poverty level; GED, General Educational Development; OR, odds ratio.</p>
                    <fn id="zoi220594t2n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Model was estimated using a 3-step method in Mplus, version 8.4, to deal with measurement errors in latent class membership estimation.</p>
                    </fn>
                    <fn id="zoi220594t2n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Statistically significant at α = .05.</p>
                    </fn>
                    <fn id="zoi220594t2n3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>Other race and ethnicity included American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, and more than 1 race.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Adolescents in the FACE-TC group compared with those in the treatment as usual group were significantly more likely to have an advance directive in the EHR at study closeout (80% [60 of 75] vs 19% [8 of 42]; <italic>P</italic> &lt; .001) (<xref rid="zoi220594t3" ref-type="table">Table 3</xref>). Documentation of goals-of-care conversations in the EHR at study closeout was low and did not differ between groups (14% [10 of 72] vs 10% [4 of 41]; <italic>P</italic> = .76) (<xref rid="zoi220594t3" ref-type="table">Table 3</xref>). Adolescents in the FACE-TC group vs the treatment as usual group had a 19-fold odds of having an advance directive in the EHR at study closeout (OR, 19.20; 95% CI, 6.84-53.88; <italic>P</italic> &lt; .05).</p>
                <table-wrap position="float" id="zoi220594t3">
                  <label>Table 3. </label>
                  <caption>
                    <title>Effect of FACE-TC on Documentation in the Electronic Health Record of Any Advance Directive or Advance Care Planning Goals of Care Discussion at Study Closeout (N = 117 Adolescents)</title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="20.8%" span="1"/>
                    <col width="30.62%" span="1"/>
                    <col width="24.29%" span="1"/>
                    <col width="24.29%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Variable</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">No. (%)</th>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">χ<sup>2</sup>
<italic>P</italic> value</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Treatment as usual group</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">FACE-TC group</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                          <bold>Any advance directive</bold>
                        </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">34 (81)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (20)</td>
                        <td rowspan="2" valign="middle" align="left" colspan="1">&lt;.001</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">60 (80)</td>
                      </tr>
                      <tr>
                        <td colspan="4" valign="top" align="left" scope="col" rowspan="1">
                          <bold>ACP goals-of-care discussion before study</bold>
                        </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">37 (90)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">62 (86)</td>
                        <td rowspan="2" valign="middle" align="left" colspan="1">.76</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 (14)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: ACP, advance care planning; FACE-TC, Family-Centered Advance Care Planning for Teens with Cancer.</p>
                  </table-wrap-foot>
                </table-wrap>
                <p>Regression analysis found no significant differences in advance directives by adolescent age, sex, and race and ethnicity as well as family household income and educational level (eTable 4 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>) or goals of care (eTable 5 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>). eTable 6 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref> provides descriptive statistics by sex and race and ethnicity.</p>
              </sec>
              <sec id="H2-9-ZOI220594">
                <title>Deaths</title>
                <p>Among the 7 adolescents who died, 6 (86%) had an advance directive in the EHR at study closeout. Five deaths occurred before completion of the protocol. Treatments that were received 30 days and 7 days before death and the last Statement of Treatment Preferences completed before death are detailed in eTable 7 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>. Of the 3 adolescents in the FACE-TC group who died, 1 died before completing a Statement of Treatment Preferences and 2 endorsed the option to stop all treatments to keep me alive in every situation. There was good congruence between adolescents and their families. The 4 adolescents in the treatment as usual group who died endorsed the option to continue all treatments or were unsure with 1 exception: stop all efforts to keep me alive was selected if the adolescent was physically impaired. There was poor congruence in 3 of the 4 dyads.</p>
              </sec>
            </sec>
            <sec id="H1-4-ZOI220594">
              <title>Discussion</title>
              <p>To our knowledge, this trial was the first to focus on the sustainability of congruence about end-of-life treatment preferences between adolescents with cancer and their families, answering the critical question “Is pACP too early?”<sup><xref rid="zoi220594r47" ref-type="bibr">47</xref>,<xref rid="zoi220594r48" ref-type="bibr">48</xref></sup> Compared with families in the treatment as usual group, families in the FACE-TC group had a greater than 3-fold odds of membership in the high-congruence latent class, accurately reporting their adolescents’ end-of-life treatment preferences over 12 months after the intervention. This finding replicates that of the FACE trial with adolescents<sup><xref rid="zoi220594r25" ref-type="bibr">25</xref></sup> and adults<sup><xref rid="zoi220594r26" ref-type="bibr">26</xref></sup> with HIV, who also had 3-fold the odds of being in the high-congruence group for 1 year after the intervention compared with the active control group. Pediatric ACP in the FACE model highlights the importance of family-centered ACP communication, which integrates communication with the clinician given that many young adults with cancer who complete the ACP document Voicing My Choices<sup><xref rid="zoi220594r4" ref-type="bibr">4</xref></sup> do not initiate an ACP conversation with their families (35%) or clinicians (91%).<sup><xref rid="zoi220594r49" ref-type="bibr">49</xref></sup></p>
              <p>The decrease in the efficacy of FACE-TC at the 18-month assessment answers another timing question: follow-up is needed at 12 months. Results support pACP as an ongoing process of regoaling (defined as relinquishing one set of goals [eg, curing the condition] and pursuing a new set of goals [eg, maintaining the child's quality of life]),<sup><xref rid="zoi220594r50" ref-type="bibr">50</xref></sup> which prepares people for future just-in-time decisions.<sup><xref rid="zoi220594r51" ref-type="bibr">51</xref></sup> With respect to goal-concordant care, adolescents in the FACE-TC group were significantly more likely to give their families leeway to do what they believed was best at the time considering the adolescents' wishes compared with adolescents in the treatment as usual group.<sup><xref rid="zoi220594r52" ref-type="bibr">52</xref></sup> Clinical outcomes for the 7 adolescents who died during the trial were complex. Although the sample was small, dying adolescents in the FACE-TC group (n = 3) wanted to stop all treatments, which had good family congruence. Dying adolescents in the treatment as usual group (n = 4) were either unsure or wanted to continue all treatments, which had poor congruence in 3 of 4 dyads. Adolescents in the FACE-TC group chose to trust their family members’ judgment to help maintain the quality of their last days of life.</p>
              <p>Interventionists entered into the EHR the advance directives of the adolescents. This structure and standardization ensured that not only were advance directives completed but also the institutional mechanisms for filing documents in the EHR were followed in a timely and correct manner. However, similar to the pilot trial,<sup><xref rid="zoi220594r29" ref-type="bibr">29</xref></sup> the documentation of goals of care in the present trial was lacking. Central, accessible, and standardized formats in the EHR and quality metrics are needed, such as care and communication bundles.<sup><xref rid="zoi220594r29" ref-type="bibr">29</xref></sup></p>
              <p>We found a race and ethnicity–based difference in the sustainability of congruence about end-of-life treatment preferences that was independent of adolescents’ preferences for continuing life-sustaining interventions. Although no race and ethnicity–based differences in congruence were found at time 1,<sup><xref rid="zoi220594r52" ref-type="bibr">52</xref></sup> over time White adolescents were 4 times more likely to achieve congruence with their families than a small population of American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, or multiracial adolescents. The importance of this finding cannot be overstated as it reflects a difference in the effect of the intervention. However, without qualitative data, we cannot explain how the intersection of racism, religion or spirituality, family dynamics, illness, and communication leads to this complex finding. Race and ethnicity–based disparities in pACP, at a minimum, depend on context, the racial and ethnic match of study personnel to participants, geography, and culture.<sup><xref rid="zoi220594r53" ref-type="bibr">53</xref>,<xref rid="zoi220594r54" ref-type="bibr">54</xref>,<xref rid="zoi220594r55" ref-type="bibr">55</xref>,<xref rid="zoi220594r56" ref-type="bibr">56</xref></sup> Data collected in an inclusive fashion and further research with an intention to address the relationship between race and ethnicity and pACP are needed.</p>
              <p>We believe this third trial of the FACE model continues to demonstrate the power of ACP conversations to maintain open communication between patients and their families. The findings contribute to the evidence base of best-practice recommendations to guide clinicians on the when, who, what, and how of end-of-life conversations with adolescents with cancer.<sup><xref rid="zoi220594r57" ref-type="bibr">57</xref></sup> There has been recent debate about the benefits of ACP.<sup><xref rid="zoi220594r58" ref-type="bibr">58</xref>,<xref rid="zoi220594r59" ref-type="bibr">59</xref>,<xref rid="zoi220594r60" ref-type="bibr">60</xref></sup> Pediatric ACP in the FACE model helps adolescents with cancer and their families make difficult decisions they may not otherwise discuss. Supporting adolescents in having a voice and enabling them to engage in difficult conversations are worth the time and effort.</p>
              <sec id="H2-10-ZOI220594">
                <title>Strengths and Limitations</title>
                <p>This study has some strengths. The findings confirm the results of 2 other trials of the FACE model,<sup><xref rid="zoi220594r25" ref-type="bibr">25</xref>,<xref rid="zoi220594r26" ref-type="bibr">26</xref></sup> using a rigorous trial design,<sup><xref rid="zoi220594r61" ref-type="bibr">61</xref></sup> vigilant blinding of assessors, and high participant retention across a 2-year period, even though the studies were conducted in different patient groups and with different interventionists. This replication of findings provides confidence in the interpretation that the FACE-TC intervention can support long-term family knowledge of their adolescent’s end-of-life treatment preferences.</p>
                <p>This study also has some limitations. The participation rate may introduce selection bias and affect generalizability. Randomization generally corrects for bias, and the participation rate was similar to that in adult dyadic longitudinal palliative care studies.<sup><xref rid="zoi220594r62" ref-type="bibr">62</xref>,<xref rid="zoi220594r63" ref-type="bibr">63</xref></sup> One-fourth of the potentially eligible dyads declined participation because they did not want to talk about pACP. Honoring an adolescent’s right to defer end-of-life decisions to their family or physician is important in showing respect for their autonomy and should not impede program implementation. Generalizability was also limited by the small number of participants from racial and ethnic minority groups. Social desirability bias could have occurred with the face-to-face administration of study questionnaires. Persons who could not speak or understand English were excluded because the intervention required the signing of a legal document. The protocol has since been adapted for Spanish-speaking participants.<sup><xref rid="zoi220594r13" ref-type="bibr">13</xref></sup> The refusal of many male adolescents to participate is consistent with the adult literature, which has shown that male individuals are generally less likely to participate in clinical trials of ACP.<sup><xref rid="zoi220594r64" ref-type="bibr">64</xref></sup> The predominance of female family members reflects that, in general, women are more likely than men to be in caregiving roles.<sup><xref rid="zoi220594r65" ref-type="bibr">65</xref></sup></p>
                <p>The results were generalizable to White female adolescents whose families reported having college-level education and access to tertiary children’s specialty hospitals. We do not know if adolescents with hematologic cancer were less likely to participate in ACP or complete an advance directive than adolescents with solid tumors, which has been found in adults.<sup><xref rid="zoi220594r66" ref-type="bibr">66</xref></sup> The results of this trial were based on a thorough analysis of the missing data to provide an estimate of end-of-life treatment congruence at 12 months after FACE-TC (eAppendix 1 in <xref rid="note-ZOI220594-1-s" ref-type="supplementary-material">Supplement 2</xref>; <xref rid="zoi220594f1" ref-type="fig">Figure 1</xref>).</p>
              </sec>
            </sec>
            <sec id="H1-5-ZOI220594">
              <title>Conclusions</title>
              <p>This randomized clinical trial found that families’ knowledge of their adolescents’ end-of-life treatment preferences was sustained for 1 year after the FACE-TC intervention, suggesting the need for yearly follow-up sessions. Race and ethnicity–based differences in the sustainability of this congruent knowledge reflect the difference in the effect of FACE-TC and require further study. The findings contribute to the when, who, what, and how of pACP with adolescents with cancer.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-ZOI220594">
              <title>References</title>
              <ref id="zoi220594r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hein</surname><given-names>K</given-names></string-name>, <string-name><surname>Knochel</surname><given-names>K</given-names></string-name>, <string-name><surname>Zaimovic</surname><given-names>V</given-names></string-name>, <etal/></person-group>. <article-title>Identifying key elements for paediatric advance care planning with parents, healthcare providers and stakeholders: a qualitative study</article-title>. <source>Palliat Med</source>. <year>2020</year>;<volume>34</volume>(<issue>3</issue>):<fpage>300</fpage>-<lpage>308</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0269216319900317</pub-id><?supplied-pmid 31985331?><pub-id pub-id-type="pmid">31985331</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Fahner</surname><given-names>JC</given-names></string-name>, <string-name><surname>Thölking</surname><given-names>TW</given-names></string-name>, <string-name><surname>Rietjens</surname><given-names>JAC</given-names></string-name>, <string-name><surname>van der Heide</surname><given-names>A</given-names></string-name>, <string-name><surname>van Delden</surname><given-names>JJM</given-names></string-name>, <string-name><surname>Kars</surname><given-names>MC</given-names></string-name></person-group>. <article-title>Towards advance care planning in pediatrics: a qualitative study on envisioning the future as parents of a seriously ill child</article-title>. <source>Eur J Pediatr</source>. <year>2020</year>;<volume>179</volume>(<issue>9</issue>):<fpage>1461</fpage>-<lpage>1468</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00431-020-03627-2</pub-id><?supplied-pmid 32193658?><pub-id pub-id-type="pmid">32193658</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lyon</surname><given-names>ME</given-names></string-name>, <string-name><surname>Garvie</surname><given-names>PA</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>L</given-names></string-name>, <string-name><surname>He</surname><given-names>J</given-names></string-name>, <string-name><surname>McCarter</surname><given-names>R</given-names></string-name>, <string-name><surname>D’Angelo</surname><given-names>LJ</given-names></string-name></person-group>. <article-title>Development, feasibility, and acceptability of the Family/Adolescent-Centered (FACE) Advance Care Planning intervention for adolescents with HIV</article-title>. <source>J Palliat Med</source>. <year>2009</year>;<volume>12</volume>(<issue>4</issue>):<fpage>363</fpage>-<lpage>372</lpage>. doi:<pub-id pub-id-type="doi">10.1089/jpm.2008.0261</pub-id><?supplied-pmid 19327074?><pub-id pub-id-type="pmid">19327074</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wiener</surname><given-names>L</given-names></string-name>, <string-name><surname>Bedoya</surname><given-names>S</given-names></string-name>, <string-name><surname>Battles</surname><given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>Voicing their choices: advance care planning with adolescents and young adults with cancer and other serious conditions</article-title>. <source>Palliat Support Care</source>. <year>2021</year>:<fpage>1</fpage>-<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S1478951521001462</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Marron</surname><given-names>JM</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>EC</given-names></string-name>, <string-name><surname>Kennedy</surname><given-names>KO</given-names></string-name></person-group>. <article-title>The complicated legacy of Cassandra Callender: ethics, decision-making, and the role of adolescents</article-title>. <source>JAMA Pediatr</source>. <year>2021</year>;<volume>175</volume>(<issue>4</issue>):<fpage>343</fpage>-<lpage>344</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.4812</pub-id><?supplied-pmid 33196794?><pub-id pub-id-type="pmid">33196794</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mack</surname><given-names>JW</given-names></string-name>, <string-name><surname>Fisher</surname><given-names>L</given-names></string-name>, <string-name><surname>Kushi</surname><given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Patient, family, and clinician perspectives on end-of-life care quality domains and candidate indicators for adolescents and young adults with cancer</article-title>. <source>JAMA Netw Open</source>. <year>2021</year>;<volume>4</volume>(<issue>8</issue>):<elocation-id>e2121888</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.21888</pub-id><?supplied-pmid 34424305?><pub-id pub-id-type="pmid">34424305</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Friebert</surname><given-names>S</given-names></string-name>, <string-name><surname>Grossoehme</surname><given-names>DH</given-names></string-name>, <string-name><surname>Baker</surname><given-names>JN</given-names></string-name>, <etal/></person-group>. <article-title>Congruence gaps between adolescents with cancer and their families regarding values, goals, and beliefs about end-of-life care</article-title>. <source>JAMA Netw Open</source>. <year>2020</year>;<volume>3</volume>(<issue>5</issue>):<elocation-id>e205424</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.5424</pub-id><?supplied-pmid 32427325?><pub-id pub-id-type="pmid">32427325</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Needle</surname><given-names>JS</given-names></string-name>, <string-name><surname>Peden-McAlpine</surname><given-names>C</given-names></string-name>, <string-name><surname>Liaschenko</surname><given-names>J</given-names></string-name></person-group>. <article-title>Physicians’ perspectives on adolescent and young adult advance care planning: the fallacy of informed decision making</article-title>. <source>J Clin Ethics</source>. <year>2019</year>;<volume>30</volume>(<issue>2</issue>):<fpage>131</fpage>-<lpage>142</lpage>.<?supplied-pmid 31188790?><pub-id pub-id-type="pmid">31188790</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Fladeboe</surname><given-names>KM</given-names></string-name>, <string-name><surname>O’Donnell</surname><given-names>MB</given-names></string-name>, <string-name><surname>Barton</surname><given-names>KS</given-names></string-name>, <etal/></person-group>. <article-title>A novel combined resilience and advance care planning intervention for adolescents and young adults with advanced cancer: a feasibility and acceptability cohort study</article-title>. <source>Cancer</source>. <year>2021</year>;<volume>127</volume>(<issue>23</issue>):<fpage>4504</fpage>-<lpage>4511</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cncr.33830</pub-id><?supplied-pmid 34358332?><pub-id pub-id-type="pmid">34358332</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>DeCourcey</surname><given-names>DD</given-names></string-name>, <string-name><surname>Partin</surname><given-names>L</given-names></string-name>, <string-name><surname>Revette</surname><given-names>A</given-names></string-name>, <string-name><surname>Bernacki</surname><given-names>R</given-names></string-name>, <string-name><surname>Wolfe</surname><given-names>J</given-names></string-name></person-group>. <article-title>Development of a stakeholder driven serious illness communication program for advance care planning in children, adolescents, and young adults with serious illness</article-title>. <source>J Pediatr</source>. <year>2021</year>;<volume>229</volume>:<fpage>247</fpage>-<lpage>258.e8</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2020.09.030</pub-id><?supplied-pmid 32949579?><pub-id pub-id-type="pmid">32949579</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Van Breemen</surname><given-names>C</given-names></string-name></person-group>. <article-title>Adapting the serious illness conversation guide for use in pediatrics</article-title>. <source>J Palliat Med</source>. <year>2018</year>;<volume>21</volume>(<issue>12</issue>):<fpage>1683</fpage>-<lpage>1683</lpage>. doi:<pub-id pub-id-type="doi">10.1089/jpm.2018.0515</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>van Driessche</surname><given-names>A</given-names></string-name>, <string-name><surname>De Vleminck</surname><given-names>A</given-names></string-name>, <string-name><surname>Gilissen</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Advance care planning for adolescents with cancer and their parents: study protocol of the BOOST pACP multi-centre randomised controlled trial and process evaluation</article-title>. <source>BMC Pediatr</source>. <year>2021</year>;<volume>21</volume>(<issue>1</issue>):<fpage>376</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12887-021-02841-7</pub-id><?supplied-pmid 34470598?><pub-id pub-id-type="pmid">34470598</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lyon</surname><given-names>ME</given-names></string-name>, <string-name><surname>Arem</surname><given-names>H</given-names></string-name>, <string-name><surname>Jacobs</surname><given-names>SS</given-names></string-name></person-group>. <article-title>Health disparities: barriers to building evidence for effective palliative end-of-life care for Spanish-speaking teens with cancer</article-title>. <source>Clin Pract Pediatr Psychol</source>. <year>2021</year>;<volume>9</volume>(<issue>3</issue>):<fpage>308</fpage>-<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1037/cpp0000417</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Katz</surname><given-names>NT</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>BH</given-names></string-name>, <string-name><surname>Hynson</surname><given-names>JL</given-names></string-name>, <string-name><surname>Heywood</surname><given-names>M</given-names></string-name>, <string-name><surname>Williams</surname><given-names>M</given-names></string-name>, <string-name><surname>Sokol</surname><given-names>J</given-names></string-name></person-group>. <article-title>Improving paediatric advance care planning: results of a learning needs analysis and simulation-based education programme</article-title>. <source>J Paediatr Child Health</source>. <year>2020</year>;<volume>56</volume>(<issue>12</issue>):<fpage>1898</fpage>-<lpage>1905</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jpc.15074</pub-id><?supplied-pmid 32812306?><pub-id pub-id-type="pmid">32812306</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Moon</surname><given-names>YJ</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J</given-names></string-name>, <string-name><surname>Choo</surname><given-names>IS</given-names></string-name>, <etal/></person-group>. <article-title>Development and application of advance care planning workbooks to facilitate communication with children and adolescent patients: a pilot test</article-title>. <source>J Hosp Palliat Care</source>. <year>2020</year>;<volume>23</volume>(<issue>4</issue>):<fpage>212</fpage>-<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.14475/kjhpc.2020.23.4.212</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Snaman</surname><given-names>JM</given-names></string-name>, <string-name><surname>Helton</surname><given-names>G</given-names></string-name>, <string-name><surname>Holder</surname><given-names>RL</given-names></string-name>, <string-name><surname>Revette</surname><given-names>A</given-names></string-name>, <string-name><surname>Baker</surname><given-names>JN</given-names></string-name>, <string-name><surname>Wolfe</surname><given-names>J</given-names></string-name></person-group>. <article-title>Identification of adolescents and young adults’ preferences and priorities for future cancer treatment using a novel decision-making tool</article-title>. <source>Pediatr Blood Cancer</source>. <year>2021</year>;<volume>68</volume>(<issue>1</issue>):<elocation-id>e28755</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/pbc.28755</pub-id><?supplied-pmid 33017087?><pub-id pub-id-type="pmid">33017087</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Horridge</surname><given-names>KA</given-names></string-name></person-group>. <article-title>Advance care planning: practicalities, legalities, complexities and controversies</article-title>. <source>Arch Dis Child</source>. <year>2015</year>;<volume>100</volume>(<issue>4</issue>):<fpage>380</fpage>-<lpage>385</lpage>. doi:<pub-id pub-id-type="doi">10.1136/archdischild-2014-305945</pub-id><?supplied-pmid 25275088?><pub-id pub-id-type="pmid">25275088</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group><collab>Section on Hospice and Palliative Medicine and Committee on Hospital Care</collab></person-group>. <article-title>Pediatric palliative care and hospice care commitments, guidelines, and recommendations</article-title>. <source>Pediatrics</source>. <year>2013</year>;<volume>132</volume>(<issue>5</issue>):<fpage>966</fpage>-<lpage>972</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2013-2731</pub-id><?supplied-pmid 28448256?><pub-id pub-id-type="pmid">28448256</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Houben</surname><given-names>CHM</given-names></string-name>, <string-name><surname>Spruit</surname><given-names>MA</given-names></string-name>, <string-name><surname>Schols</surname><given-names>JMGA</given-names></string-name>, <string-name><surname>Wouters</surname><given-names>EFM</given-names></string-name>, <string-name><surname>Janssen</surname><given-names>DJA</given-names></string-name></person-group>. <article-title>Instability of willingness to accept life-sustaining treatments in patients with advanced chronic organ failure during 1 year</article-title>. <source>Chest</source>. <year>2017</year>;<volume>151</volume>(<issue>5</issue>):<fpage>1081</fpage>-<lpage>1087</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2016.12.003</pub-id><?supplied-pmid 28007621?><pub-id pub-id-type="pmid">28007621</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Jabbarian</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Maciejewski</surname><given-names>RC</given-names></string-name>, <string-name><surname>Maciejewski</surname><given-names>PK</given-names></string-name>, <etal/></person-group>. <article-title>The stability of treatment preferences among patients with cancer</article-title>. <source>J Pain Symptom Manage</source>. <year>2019</year>;<volume>57</volume>(<issue>6</issue>):<fpage>1071</fpage>-<lpage>1079.e1</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpainsymman.2019.01.016</pub-id><?supplied-pmid 30794935?><pub-id pub-id-type="pmid">30794935</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r21">
                <label>21</label>
                <mixed-citation publication-type="webpage"><person-group><collab>American Cancer Society</collab></person-group>. Cancer Facts &amp; Figures, 2020. Accessed March 1, 2022. <ext-link xlink:href="https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html" ext-link-type="uri">https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html</ext-link></mixed-citation>
              </ref>
              <ref id="zoi220594r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Miller</surname><given-names>KD</given-names></string-name>, <string-name><surname>Fidler-Benaoudia</surname><given-names>M</given-names></string-name>, <string-name><surname>Keegan</surname><given-names>TH</given-names></string-name>, <string-name><surname>Hipp</surname><given-names>HS</given-names></string-name>, <string-name><surname>Jemal</surname><given-names>A</given-names></string-name>, <string-name><surname>Siegel</surname><given-names>RL</given-names></string-name></person-group>. <article-title>Cancer statistics for adolescents and young adults, 2020</article-title>. <source>CA Cancer J Clin</source>. <year>2020</year>;<volume>70</volume>(<issue>6</issue>):<fpage>443</fpage>-<lpage>459</lpage>. doi:<pub-id pub-id-type="doi">10.3322/caac.21637</pub-id><?supplied-pmid 32940362?><pub-id pub-id-type="pmid">32940362</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Suh</surname><given-names>E</given-names></string-name>, <string-name><surname>Stratton</surname><given-names>KL</given-names></string-name>, <string-name><surname>Leisenring</surname><given-names>WM</given-names></string-name>, <etal/></person-group>. <article-title>Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study</article-title>. <source>Lancet Oncol</source>. <year>2020</year>;<volume>21</volume>(<issue>3</issue>):<fpage>421</fpage>-<lpage>435</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1470-2045(19)30800-9</pub-id><?supplied-pmid 32066543?><pub-id pub-id-type="pmid">32066543</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Jacobs</surname><given-names>S</given-names></string-name>, <string-name><surname>Perez</surname><given-names>J</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>YI</given-names></string-name>, <string-name><surname>Sill</surname><given-names>A</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Lyon</surname><given-names>ME</given-names></string-name></person-group>. <article-title>Adolescent end of life preferences and congruence with their parents’ wishes: results of a survey of adolescents with cancer</article-title>. <source>Pediatr Blood Cancer</source>. <year>2015</year>;<volume>62</volume>(<issue>4</issue>):<fpage>710</fpage>-<lpage>714</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pbc.25358</pub-id><?supplied-pmid 25545105?><pub-id pub-id-type="pmid">25545105</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lyon</surname><given-names>ME</given-names></string-name>, <string-name><surname>Garvie</surname><given-names>PA</given-names></string-name>, <string-name><surname>D’Angelo</surname><given-names>LJ</given-names></string-name>, <etal/>; <collab>Adolescent Palliative Care Consortium</collab></person-group>. <article-title>Advance care planning and HIV symptoms in adolescence</article-title>. <source>Pediatrics</source>. <year>2018</year>;<volume>142</volume>(<issue>5</issue>):<elocation-id>e20173869</elocation-id>. doi:<pub-id pub-id-type="doi">10.1542/peds.2017-3869</pub-id><?supplied-pmid 30341154?><pub-id pub-id-type="pmid">30341154</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lyon</surname><given-names>ME</given-names></string-name>, <string-name><surname>Caceres</surname><given-names>S</given-names></string-name>, <string-name><surname>Scott</surname><given-names>RK</given-names></string-name>, <etal/>; <collab>Palliative Care Consortium</collab></person-group>. <article-title>Advance care planning–complex and working: longitudinal trajectory of congruence in end-of-life treatment preferences: an RCT</article-title>. <source>Am J Hosp Palliat Care</source>. <year>2021</year>;<volume>38</volume>(<issue>6</issue>):<fpage>634</fpage>-<lpage>643</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1049909121991807</pub-id><?supplied-pmid 33530701?><pub-id pub-id-type="pmid">33530701</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lyon</surname><given-names>ME</given-names></string-name>, <string-name><surname>Jacobs</surname><given-names>S</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>L</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>YI</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J</given-names></string-name></person-group>. <article-title>A longitudinal, randomized, controlled trial of advance care planning for teens with cancer: anxiety, depression, quality of life, advance directives, spirituality</article-title>. <source>J Adolesc Health</source>. <year>2014</year>;<volume>54</volume>(<issue>6</issue>):<fpage>710</fpage>-<lpage>717</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jadohealth.2013.10.206</pub-id><?supplied-pmid 24411819?><pub-id pub-id-type="pmid">24411819</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lyon</surname><given-names>ME</given-names></string-name>, <string-name><surname>Jacobs</surname><given-names>S</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>L</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>YI</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J</given-names></string-name></person-group>. <article-title>Family-centered advance care planning for teens with cancer</article-title>. <source>JAMA Pediatr</source>. <year>2013</year>;<volume>167</volume>(<issue>5</issue>):<fpage>460</fpage>-<lpage>467</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2013.943</pub-id><?supplied-pmid 23479062?><pub-id pub-id-type="pmid">23479062</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Watson</surname><given-names>A</given-names></string-name>, <string-name><surname>Weaver</surname><given-names>M</given-names></string-name>, <string-name><surname>Jacobs</surname><given-names>S</given-names></string-name>, <string-name><surname>Lyon</surname><given-names>ME</given-names></string-name></person-group>. <article-title>Interdisciplinary communication: documentation of advance care planning and end-of-life care in adolescents and young adults with cancer</article-title>. <source>J Hosp Palliat Nurs</source>. <year>2019</year>;<volume>21</volume>(<issue>3</issue>):<fpage>215</fpage>-<lpage>222</lpage>. doi:<pub-id pub-id-type="doi">10.1097/NJH.0000000000000512</pub-id><?supplied-pmid 30829829?><pub-id pub-id-type="pmid">30829829</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Needle</surname><given-names>JS</given-names></string-name>, <string-name><surname>Peden-McAlpine</surname><given-names>C</given-names></string-name>, <string-name><surname>Liaschenko</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>“Can you tell me why you made that choice?”: a qualitative study of the influences on treatment decisions in advance care planning among adolescents and young adults undergoing bone marrow transplant</article-title>. <source>Palliat Med</source>. <year>2020</year>;<volume>34</volume>(<issue>3</issue>):<fpage>281</fpage>-<lpage>290</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0269216319883977</pub-id><?supplied-pmid 31659933?><pub-id pub-id-type="pmid">31659933</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Needle</surname><given-names>J</given-names></string-name>, <string-name><surname>Brunnquel</surname><given-names>D</given-names></string-name>, <string-name><surname>Lyon</surname><given-names>M</given-names></string-name>, <string-name><surname>Heith</surname><given-names>C</given-names></string-name></person-group>. <article-title>Mature minors, mature decisions: advance care planning for adolescent patients with life-limiting illness</article-title>. <source>J Pediatr Ethics</source>. <year>2018</year>;<volume>1</volume>(<issue>3</issue>).</mixed-citation>
              </ref>
              <ref id="zoi220594r32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Curtin</surname><given-names>KB</given-names></string-name>, <string-name><surname>Watson</surname><given-names>AE</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Okonkwo</surname><given-names>OC</given-names></string-name>, <string-name><surname>Lyon</surname><given-names>ME</given-names></string-name></person-group>. <article-title>Pediatric advance care planning (pACP) for teens with cancer and their families: design of a dyadic, longitudinal RCCT</article-title>. <source>Contemp Clin Trials</source>. <year>2017</year>;<volume>62</volume>:<fpage>121</fpage>-<lpage>129</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cct.2017.08.016</pub-id><?supplied-pmid 28844985?><pub-id pub-id-type="pmid">28844985</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r33">
                <label>33</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Beck</surname><given-names>AT</given-names></string-name>, <string-name><surname>Steer</surname><given-names>RA</given-names></string-name>, <string-name><surname>Brown</surname><given-names>GK</given-names></string-name></person-group>. <source>Manual for the Beck Depression Inventory-II</source>. <publisher-name>Psychological Corporation</publisher-name>; <year>1996</year>.</mixed-citation>
              </ref>
              <ref id="zoi220594r34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Shaffer</surname><given-names>D</given-names></string-name>, <string-name><surname>Fisher</surname><given-names>P</given-names></string-name>, <string-name><surname>Dulcan</surname><given-names>MK</given-names></string-name>, <etal/></person-group>. <article-title>The NIMH Diagnostic Interview Schedule for Children, Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA study</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>1996</year>;<volume>35</volume>(<issue>7</issue>):<fpage>865</fpage>-<lpage>877</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00004583-199607000-00012</pub-id><?supplied-pmid 8768346?><pub-id pub-id-type="pmid">8768346</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r35">
                <label>35</label>
                <mixed-citation publication-type="webpage"><person-group><string-name><surname>Hammes</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>L</given-names></string-name></person-group>, Schellinger S. Next steps: ACP facilitator certification. Accessed March 5, 2022. <ext-link xlink:href="https://respectingchoices.org/advance-care-planning-courses" ext-link-type="uri">https://respectingchoices.org/advance-care-planning-courses</ext-link></mixed-citation>
              </ref>
              <ref id="zoi220594r36">
                <label>36</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Hammes</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>L</given-names></string-name></person-group>. <source>Respecting Choices: Palliative Care Facilitator Manual</source>. <publisher-name>Gundersen Lutheran Medical Foundation</publisher-name>; <year>2000</year>.</mixed-citation>
              </ref>
              <ref id="zoi220594r37">
                <label>37</label>
                <mixed-citation publication-type="webpage"><person-group><string-name><surname>Wikinson</surname><given-names>D</given-names></string-name>, <string-name><surname>Gillam</surname><given-names>L</given-names></string-name>, <string-name><surname>Hynson</surname><given-names>J</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>J</given-names></string-name>, <string-name><surname>Yafis</surname><given-names>V</given-names></string-name></person-group>. Caring decisions: a handbook for parents facing end-of-life decisions for their child. The Royal Children’s Hospital. Accessed August 7, 2020. <ext-link xlink:href="https://www.rch.org.au/uploadedFiles/Main/Content/caringdecisions/130890%20Caring%20Decisions%20book_v1.pdf" ext-link-type="uri">https://www.rch.org.au/uploadedFiles/Main/Content/caringdecisions/130890%20Caring%20Decisions%20book_v1.pdf</ext-link></mixed-citation>
              </ref>
              <ref id="zoi220594r38">
                <label>38</label>
                <mixed-citation publication-type="webpage"><person-group><string-name><surname>Towey</surname><given-names>E</given-names></string-name></person-group>. Five wishes. Accessed April 18, 2021. <ext-link xlink:href="https://agingwithdignity.org/" ext-link-type="uri">https://agingwithdignity.org/</ext-link></mixed-citation>
              </ref>
              <ref id="zoi220594r39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>MacKenzie</surname><given-names>MA</given-names></string-name>, <string-name><surname>Smith-Howell</surname><given-names>E</given-names></string-name>, <string-name><surname>Bomba</surname><given-names>PA</given-names></string-name>, <string-name><surname>Meghani</surname><given-names>SH</given-names></string-name></person-group>. <article-title>Respecting Choices and related models of advance care planning: a systematic review of published evidence</article-title>. <source>Am J Hosp Palliat Care</source>. <year>2018</year>;<volume>35</volume>(<issue>6</issue>):<fpage>897</fpage>-<lpage>907</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1049909117745789</pub-id><?supplied-pmid 29254357?><pub-id pub-id-type="pmid">29254357</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Feldman</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Masyn</surname><given-names>KE</given-names></string-name>, <string-name><surname>Conger</surname><given-names>RD</given-names></string-name></person-group>. <article-title>New approaches to studying problem behaviors: a comparison of methods for modeling longitudinal, categorical adolescent drinking data</article-title>. <source>Dev Psychol</source>. <year>2009</year>;<volume>45</volume>(<issue>3</issue>):<fpage>652</fpage>-<lpage>676</lpage>. doi:<pub-id pub-id-type="doi">10.1037/a0014851</pub-id><?supplied-pmid 19413423?><pub-id pub-id-type="pmid">19413423</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lanza</surname><given-names>ST</given-names></string-name>, <string-name><surname>Collins</surname><given-names>LM</given-names></string-name></person-group>. <article-title>A mixture model of discontinuous development in heavy drinking from ages 18 to 30: the role of college enrollment</article-title>. <source>J Stud Alcohol</source>. <year>2006</year>;<volume>67</volume>(<issue>4</issue>):<fpage>552</fpage>-<lpage>561</lpage>. doi:<pub-id pub-id-type="doi">10.15288/jsa.2006.67.552</pub-id><?supplied-pmid 16736075?><pub-id pub-id-type="pmid">16736075</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r42">
                <label>42</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name></person-group>. <source>Structural Equation Modeling: Applications Using Mplus</source>. <publisher-name>John Wiley &amp; Sons Inc</publisher-name>; <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="zoi220594r43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Asparouhov</surname><given-names>T</given-names></string-name>, <string-name><surname>Muthén</surname><given-names>B</given-names></string-name></person-group>. <article-title>Auxiliary variables in mixture modeling: three-step approaches using Mplus</article-title>. <source>Struct Equ Modeling</source>. <year>2014</year>;<volume>21</volume>(3):<fpage>329</fpage>-<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1080/10705511.2014.915181</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Vermunt</surname><given-names>JK</given-names></string-name></person-group>. <article-title>Latent class modeling with covariates: two improved three-step approaches</article-title>. <source>Polit Anal</source>. <year>2010</year>;<volume>18 </volume>(4):<fpage>450</fpage>-<lpage>469</lpage>. doi:<pub-id pub-id-type="doi">10.1093/pan/mpq025</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r45">
                <label>45</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Muthén</surname><given-names>LK</given-names></string-name>, <string-name><surname>Muthén</surname><given-names>BO</given-names></string-name></person-group>. <italic>Mplus User’s Guide</italic>. <edition>8th ed</edition>. <publisher-name>Muthén &amp; Muthén</publisher-name>; 1998-2017. Accessed June 22, 2022. <ext-link xlink:href="https://www.statmodel.com/download/usersguide/MplusUserGuideVer_8.pdf" ext-link-type="uri">https://www.statmodel.com/download/usersguide/MplusUserGuideVer_8.pdf</ext-link></mixed-citation>
              </ref>
              <ref id="zoi220594r46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Harris</surname><given-names>PA</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>R</given-names></string-name>, <string-name><surname>Thielke</surname><given-names>R</given-names></string-name>, <string-name><surname>Payne</surname><given-names>J</given-names></string-name>, <string-name><surname>Gonzalez</surname><given-names>N</given-names></string-name>, <string-name><surname>Conde</surname><given-names>JG</given-names></string-name></person-group>. <article-title>Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support</article-title>. <source>J Biomed Inform</source>. <year>2009</year>;<volume>42</volume>(<issue>2</issue>):<fpage>377</fpage>-<lpage>381</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbi.2008.08.010</pub-id><?supplied-pmid 18929686?><pub-id pub-id-type="pmid">18929686</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r47">
                <label>47</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Field</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Behrman</surname><given-names>RE</given-names></string-name></person-group>, eds. <source>When Children Die: Improving Palliative and End-of-Life Care for Children and Their Families</source>. <publisher-name>National Academies Press</publisher-name>; <year>2003</year>.</mixed-citation>
              </ref>
              <ref id="zoi220594r48">
                <label>48</label>
                <mixed-citation publication-type="book">Committee on Approaching Death: Addressing Key End of Life Issues; Institute of Medicine. <source>Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life</source>. <publisher-name>National Academies Press</publisher-name>; <year>2015</year>.</mixed-citation>
              </ref>
              <ref id="zoi220594r49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bedoya</surname><given-names>SZ</given-names></string-name>, <string-name><surname>Fry</surname><given-names>A</given-names></string-name>, <string-name><surname>Gordon</surname><given-names>ML</given-names></string-name></person-group>. <article-title>Adolescent and young adult initiated discussions of advance care planning: family member, friend and health care provider perspectives</article-title>. <source>Front Psychol</source>. Published online June 8, 2022. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2022.871042</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hill</surname><given-names>DL</given-names></string-name>, <string-name><surname>Miller</surname><given-names>V</given-names></string-name>, <string-name><surname>Walter</surname><given-names>JK</given-names></string-name>, <etal/></person-group>. <article-title>Regoaling: a conceptual model of how parents of children with serious illness change medical care goals</article-title>. <source>BMC Palliat Care</source>. <year>2014</year>;<volume>13</volume>(<issue>1</issue>):<fpage>9</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1472-684X-13-9</pub-id><?supplied-pmid 24625345?><pub-id pub-id-type="pmid">24625345</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sudore</surname><given-names>RL</given-names></string-name>, <string-name><surname>Fried</surname><given-names>TR</given-names></string-name></person-group>. <article-title>Redefining the “planning” in advance care planning: preparing for end-of-life decision making</article-title>. <source>Ann Intern Med</source>. <year>2010</year>;<volume>153</volume>(<issue>4</issue>):<fpage>256</fpage>-<lpage>261</lpage>. doi:<pub-id pub-id-type="doi">10.7326/0003-4819-153-4-201008170-00008</pub-id><?supplied-pmid 20713793?><pub-id pub-id-type="pmid">20713793</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Baker</surname><given-names>JN</given-names></string-name>, <string-name><surname>Friebert</surname><given-names>S</given-names></string-name>, <string-name><surname>Needle</surname><given-names>J</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>J</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Lyon</surname><given-names>ME</given-names></string-name></person-group>. <article-title>An intervention in congruence for end-of-life treatment preference: a randomized trial</article-title>. <source>Pediatrics</source>. <year>2022</year>;<volume>149</volume>(<issue>5</issue>):<elocation-id>e2021054796</elocation-id>. doi:<pub-id pub-id-type="doi">10.1542/peds.2021-054796</pub-id><?supplied-pmid 35425986?><pub-id pub-id-type="pmid">35425986</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bullock</surname><given-names>K</given-names></string-name></person-group>. <article-title>The influence of culture on end-of-life decision making</article-title>. <source>J Soc Work End Life Palliat Care</source>. <year>2011</year>;<volume>7</volume>(<issue>1</issue>):<fpage>83</fpage>-<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15524256.2011.548048</pub-id><?supplied-pmid 21391079?><pub-id pub-id-type="pmid">21391079</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sanders</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>MT</given-names></string-name>, <string-name><surname>Block</surname><given-names>SD</given-names></string-name></person-group>. <article-title>Factors impacting advance care planning among African Americans: results of a systematic integrated review</article-title>. <source>J Palliat Med</source>. <year>2016</year>;<volume>19</volume>(<issue>2</issue>):<fpage>202</fpage>-<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1089/jpm.2015.0325</pub-id><?supplied-pmid 26840857?><pub-id pub-id-type="pmid">26840857</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Troyer</surname><given-names>JL</given-names></string-name>, <string-name><surname>McAuley</surname><given-names>WJ</given-names></string-name></person-group>. <article-title>Environmental contexts of ultimate decisions: why White nursing home residents are twice as likely as African American residents to have an advance directive</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source>. <year>2006</year>;<volume>61</volume>(<issue>4</issue>):<fpage>S194</fpage>-<lpage>S202</lpage>. doi:<pub-id pub-id-type="doi">10.1093/geronb/61.4.S194</pub-id><?supplied-pmid 16855040?><pub-id pub-id-type="pmid">16855040</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Elk</surname><given-names>R</given-names></string-name>, <string-name><surname>Emanuel</surname><given-names>L</given-names></string-name>, <string-name><surname>Hauser</surname><given-names>J</given-names></string-name>, <string-name><surname>Bakitas</surname><given-names>M</given-names></string-name>, <string-name><surname>Levkoff</surname><given-names>S</given-names></string-name></person-group>. <article-title>Developing and testing the feasibility of a culturally based tele-palliative care consult based on the cultural values and preferences of southern, rural African American and White community members: a program by and for the community</article-title>. <source>Health Equity</source>. <year>2020</year>;<volume>4</volume>(<issue>1</issue>):<fpage>52</fpage>-<lpage>83</lpage>. doi:<pub-id pub-id-type="doi">10.1089/heq.2019.0120</pub-id><?supplied-pmid 32258958?><pub-id pub-id-type="pmid">32258958</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sansom-Daly</surname><given-names>UM</given-names></string-name>, <string-name><surname>Wakefield</surname><given-names>CE</given-names></string-name>, <string-name><surname>Patterson</surname><given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>End-of-life communication needs for adolescents and young adults with cancer: recommendations for research and practice</article-title>. <source>J Adolesc Young Adult Oncol</source>. <year>2020</year>;<volume>9</volume>(<issue>2</issue>):<fpage>157</fpage>-<lpage>165</lpage>. doi:<pub-id pub-id-type="doi">10.1089/jayao.2019.0084</pub-id><?supplied-pmid 31660768?><pub-id pub-id-type="pmid">31660768</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Morrison</surname><given-names>RS</given-names></string-name>, <string-name><surname>Meier</surname><given-names>DE</given-names></string-name>, <string-name><surname>Arnold</surname><given-names>RM</given-names></string-name></person-group>. <article-title>What’s wrong with advance care planning?</article-title><source>JAMA</source>. <year>2021</year>;<volume>326</volume>(<issue>16</issue>):<fpage>1575</fpage>-<lpage>1576</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2021.16430</pub-id><?supplied-pmid 34623373?><pub-id pub-id-type="pmid">34623373</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Weaver</surname><given-names>MS</given-names></string-name>, <string-name><surname>Wiener</surname><given-names>L</given-names></string-name>, <string-name><surname>Jacobs</surname><given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Weaver et al’s response to Morrison: advance directives/care planning: clear, simple, and wrong (DOI: 10.1089/jpm.2020.0272)</article-title>. <source>J Palliat Med</source>. <year>2021</year>;<volume>24</volume>(<issue>1</issue>):<fpage>8</fpage>-<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1089/jpm.2020.0486</pub-id><?supplied-pmid 32865470?><pub-id pub-id-type="pmid">32865470</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Curtis</surname><given-names>JR</given-names></string-name></person-group>. <article-title>Three stories about the value of advance care planning</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>326</volume>(<issue>21</issue>):<fpage>2133</fpage>-<lpage>2134</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2021.21075</pub-id><?supplied-pmid 34874415?><pub-id pub-id-type="pmid">34874415</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>McCoy</surname><given-names>CE</given-names></string-name></person-group>. <article-title>Understanding the intention-to-treat principle in randomized controlled trials</article-title>. <source>West J Emerg Med</source>. <year>2017</year>;<volume>18</volume>(<issue>6</issue>):<fpage>1075</fpage>-<lpage>1078</lpage>. doi:<pub-id pub-id-type="doi">10.5811/westjem.2017.8.35985</pub-id><?supplied-pmid 29085540?><pub-id pub-id-type="pmid">29085540</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kirchhoff</surname><given-names>KT</given-names></string-name>, <string-name><surname>Kehl</surname><given-names>KA</given-names></string-name></person-group>. <article-title>Recruiting participants in end-of-life research</article-title>. <source>Am J Hosp Palliat Care</source>. <year>2007</year>;<volume>24</volume>(<issue>6</issue>):<fpage>515</fpage>-<lpage>521</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1049909107300551</pub-id><?supplied-pmid 17601835?><pub-id pub-id-type="pmid">17601835</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bakitas</surname><given-names>M</given-names></string-name>, <string-name><surname>Lyons</surname><given-names>KD</given-names></string-name>, <string-name><surname>Hegel</surname><given-names>MT</given-names></string-name>, <etal/></person-group>. <article-title>Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>302</volume>(<issue>7</issue>):<fpage>741</fpage>-<lpage>749</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2009.1198</pub-id><?supplied-pmid 19690306?><pub-id pub-id-type="pmid">19690306</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bischoff</surname><given-names>KE</given-names></string-name>, <string-name><surname>Sudore</surname><given-names>R</given-names></string-name>, <string-name><surname>Miao</surname><given-names>Y</given-names></string-name>, <string-name><surname>Boscardin</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Smith</surname><given-names>AK</given-names></string-name></person-group>. <article-title>Advance care planning and the quality of end-of-life care in older adults</article-title>. <source>J Am Geriatr Soc</source>. <year>2013</year>;<volume>61</volume>(<issue>2</issue>):<fpage>209</fpage>-<lpage>214</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jgs.12105</pub-id><?supplied-pmid 23350921?><pub-id pub-id-type="pmid">23350921</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Gott</surname><given-names>M</given-names></string-name>, <string-name><surname>Morgan</surname><given-names>T</given-names></string-name>, <string-name><surname>Williams</surname><given-names>L</given-names></string-name></person-group>. <article-title>Gender and palliative care: a call to arms</article-title>. <source>Palliat Care Soc Pract</source>. <year>2020</year>;<volume>14</volume>:<elocation-id>2632352420957997</elocation-id>. doi:<pub-id pub-id-type="doi">10.1177/2632352420957997</pub-id><?supplied-pmid 33134926?><pub-id pub-id-type="pmid">33134926</pub-id></mixed-citation>
              </ref>
              <ref id="zoi220594r66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>LeBlanc</surname><given-names>TW</given-names></string-name>, <string-name><surname>El-Jawahri</surname><given-names>A</given-names></string-name></person-group>. <article-title>When and why should patients with hematologic malignancies see a palliative care specialist?</article-title><source>Hematology Am Soc Hematol Educ Program</source>. <year>2015</year>;<volume>2015</volume>:<fpage>471</fpage>-<lpage>478</lpage>. doi:<pub-id pub-id-type="doi">10.1182/asheducation-2015.1.471</pub-id><?supplied-pmid 26637760?><pub-id pub-id-type="pmid">26637760</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-ZOI220594-1">
              <supplementary-material id="note-ZOI220594-1-s" position="float" content-type="local-data">
                <label>Supplement 1.</label>
                <caption>
                  <p>
Trial Protocol
</p>
                </caption>
                <media xlink:href="jamanetwopen-e2220696-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 2.</label>
                <caption>
                  <p><bold>eAppendix 1.</bold> Additional Details for Latent Class Analysis for Hypotheses 1</p>
                  <p><bold>eTable 1.</bold> FAmily CEntered (FACE) Advance Care Planning Intervention</p>
                  <p><bold>eAppendix 2.</bold> Descriptive Statistics of the Congruence Measure by Latent Classes</p>
                  <p><bold>eTable 2.</bold> Selected Results of Longitudinal Latent Class Analysis (LLCA) for Congruence Between Patient and Family Over Time Regarding Treatment Preference in Four Medical Situations (N=117 Dyads)</p>
                  <p><bold>eTable 3.</bold> Effect of Intervention on Latent Class Classification, Results of Logistic Regression Model Using 3-step Procedure for the 4-time Point Data (T1-T4) (N=117 Dyads)</p>
                  <p><bold>eTable 4.</bold> Intervention Effect on Odds of Having Completed Any Advance Directive Documented in the Electronic Health Record at Study Close-out: Results of Logistic Regression (N=117 Dyads)</p>
                  <p><bold>eTable 5.</bold> Intervention Effect on Odds of Having Completed ACP Goals of Care Discussion Documented in Electronic Health Record at Study Close Out: Results of Logistic Regression (N=117 Dyads)</p>
                  <p><bold>eTable 6.</bold> Documentation in the Electronic Health Record of Any Advance Directive or Advance Care Planning Goals of Care Discussion at Study Close Out by Gender and Race</p>
                  <p><bold>eTable 7.</bold> Health Care Utilization 30 Days and 7 Days Prior to Death from the Electronic Patient Health Record Form (N=7 Adolescents)</p>
                </caption>
                <media xlink:href="jamanetwopen-e2220696-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 3.</label>
                <caption>
                  <p>
Data Sharing Statement
</p>
                </caption>
                <media xlink:href="jamanetwopen-e2220696-s00.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
